Poly(lactic acid) (PLA)-based biocomposites incorporating collagen (COLL) and hydroxyapatite (HA) were produced via melt micro-compounding and subsequent injection molding. 1,4-phenylene diisocyanate (PDI) was employed as a compatibilizer, while poly(ethylene glycol) (PEG) was used as a plasticizer. The morphological, thermal, rheological, and mechanical properties, as well as surface wettability, degradation behavior, and cytotoxicity, were comprehensively evaluated. SEM and DSC analyses revealed the phase distribution and thermal transitions, while rheological measurements showed that PEG reduced melt viscosity by increasing chain mobility. Mechanical performance was evaluated using tensile, impact, and DMA tests on standard specimens, indicating that HA primarily enhanced stiffness (elastic modulus), whereas PEG improved toughness, resulting in higher impact strength. Biodegradable bone screw prototypes were produced with the same formulations and subjected to torsion, enzymatic degradation, and MTT cytotoxicity tests. Degradation results indicated that biocomposites containing PEG, collagen, and HA exhibited accelerated mass loss. Overall, the 70/20/10 PLA/COLL/HA/PEG/PDI formulation was more suitable for soft (trabecular) bone tissue, while the 70/10/20 PLA/COLL/HA/PDI formulation showed advantages for hard (cortical) bone tissue applications.
Uzuner‐Demir et al. (2026) studied this question.